Hochschulschrift
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
- Language
-
Englisch
- Extent
-
Online-Ressource
- Notes
-
Mainz, Johannes Gutenberg-Universität, Dissertation, 2017
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Keyword
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Creator
- Event
-
Veröffentlichung
- (where)
-
Mainz
- (who)
-
Universitätsbibliothek Mainz
- (when)
-
2017
- URN
-
urn:nbn:de:hebis:77-diss-1000009998
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Wegner, Anja
- Universitätsbibliothek Mainz
Time of origin
- 2017
Other Objects (12)
Cellular and circuit mechanisms of anti-NMDA receptor autoimmune encephalitis
Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
The contribution of TNF from distinct cellular sources to autoimmune colitis
Cellular immunotherapy in patients with advanced Ewing sarcoma
Polymer-induced tumor immunotherapy by in situ activation of antigen-presenting cells
HNSCC: tumour antigens and their targeting by immunotherapy
Cellular antigens : lectures and summaries of the Conference on Cellular Antigens, held in Philadelphia, June 7 - 9, 1971
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Evaluation of D-TMPP for use in diagnosis and specific cellular immunotherapy of prostate cancer
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Cellular and circuit mechanisms of anti-NMDA receptor autoimmune encephalitis
Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
The contribution of TNF from distinct cellular sources to autoimmune colitis
Cellular immunotherapy in patients with advanced Ewing sarcoma
Polymer-induced tumor immunotherapy by in situ activation of antigen-presenting cells
HNSCC: tumour antigens and their targeting by immunotherapy
Cellular antigens : lectures and summaries of the Conference on Cellular Antigens, held in Philadelphia, June 7 - 9, 1971
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Evaluation of D-TMPP for use in diagnosis and specific cellular immunotherapy of prostate cancer
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Cellular and circuit mechanisms of anti-NMDA receptor autoimmune encephalitis
Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
The contribution of TNF from distinct cellular sources to autoimmune colitis
Cellular immunotherapy in patients with advanced Ewing sarcoma
Polymer-induced tumor immunotherapy by in situ activation of antigen-presenting cells
HNSCC: tumour antigens and their targeting by immunotherapy
Cellular antigens : lectures and summaries of the Conference on Cellular Antigens, held in Philadelphia, June 7 - 9, 1971
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Evaluation of D-TMPP for use in diagnosis and specific cellular immunotherapy of prostate cancer
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy